Article
Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.
AIDS (London, England) - 11 May 2007
Oyugi Jessica H, Byakika-Tusiime Jayne, Ragland Kathleen, Laeyendecker Oliver, Mugerwa Roy, Kityo Cissy, Mugyenyi Peter, Quinn Thomas C, Bangsberg David R
Abstract excerpt
OBJECTIVE: To evaluate adherence, treatment interruptions, and outcomes in patients purchasing antiretroviral fixed-dose combination (FDC) therapy. DESIGN: Ninety-seven participants were recruited into a prospective 24-week observational cohort study of HIV-positive, antiretroviral-naive individuals initiating self-pay Triomune or Maxivir therapy in Kampala, Uganda. Adherence was measured by monthly structured...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
